On August 30, 2024, James Swift, CEO of Pediatrix Medical Group Inc (MD, Financial), executed a sale of 11,100 shares of the company, according to the SEC Filing. Post-transaction, the insider owns 170,001 shares of the company.
Pediatrix Medical Group Inc specializes in providing hospital-based maternal-fetal, newborn, and pediatric subspecialty care. The company offers its services across various states, focusing on improving clinical outcomes for mothers, babies, and children.
Over the past year, James Swift has sold a total of 16,864 shares and has not purchased any shares. This recent transaction continues a trend seen within the company, where there have been five insider sells and no insider buys over the past year.
Shares of Pediatrix Medical Group Inc were trading at $10.79 on the day of the transaction. The company currently has a market cap of $915.331 million.
The stock's valuation metrics, such as the price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, contribute to the GF Value of $15.58. With the current price of $10.79, the stock has a price-to-GF-Value ratio of 0.69, indicating it is a Possible Value Trap, Think Twice.
This insider sale might draw attention from investors, considering the insider's significant remaining stake and the current market valuation of the company.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
